|

Part C - Safety expansion cohort in participants with axSpA Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Grey Wolf Therapeutics1

Indications

  • Axial Spondyloarthritis (AxSpA)1
  • Arthritis1

Other1 trial

EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.